College Factual  by our College Data Analytics Team
       Unbiased Factual Guarantee

Temple University Master’s in Clinical and Industrial Drug Development

88 Master's Degrees Awarded
YES Online Classes

Clinical and Industrial Drug Development is a concentration offered under the pharmacy/pharmaceutical sciences major at Temple University. We’ve gathered data and other essential information about the master’s degree program in clinical and industrial drug development, such as if the program is offered online, ethnicity of students, how many students graduated in recent times, and more.

You can jump to any section of this page using the links below:

How Much Does a Master’s in Clinical and Industrial Drug Development from Temple Cost?

$17,846 Average Tuition and Fees

Temple Graduate Tuition and Fees

Out-of-state part-time graduates at Temple paid an average of $1,297 per credit hour in 2019-2020. The average for in-state students was $942 per credit hour. Information about average full-time graduate student tuition and fees is shown in the table below.

In StateOut of State
Tuition$16,956$23,346
Fees$890$890

Does Temple Offer an Online Master’s in Clinical and Industrial Drug Development?

If you’re interested in online learning, you’re in luck. Temple does offer online classes in its clinical and industrial drug development master’s degree program. To see if the school offers distance learning options in other areas, visit the Temple Online Learning page.

Temple Master’s Student Diversity for Clinical and Industrial Drug Development

88 Master's Degrees Awarded
72.7% Women
20.5% Racial-Ethnic Minorities*
In the 2019-2020 academic year, 88 students received their master’s degree in clinical and industrial drug development. The gender and racial-ethnic breakdown of those individuals is shown below.

Male-to-Female Ratio

About 72.7% of the students who received their Master’s in clinical and industrial drug development in 2019-2020 were women. This is about the same as the countrywide number of 71.4%.

undefined

Racial-Ethnic Diversity

Of those graduates who received a master’s degree in clinical and industrial drug development at Temple in 2019-2020, 20.5% were racial-ethnic minorities*. This is lower than the nationwide number of 29%.

undefined
Race/EthnicityNumber of Students
Asian11
Black or African American6
Hispanic or Latino0
Native American or Alaska Native0
Native Hawaiian or Pacific Islander0
White11
International Students3
Other Races/Ethnicities57

You may also be interested in one of these majors related to clinical and industrial drug development.

Related MajorAnnual Graduates
Pharmaceutics and Drug Design5

View All Clinical and Industrial Drug Development Related Majors >

References

*The racial-ethnic minorities count is calculated by taking the total number of students and subtracting white students, international students, and students whose race/ethnicity was unknown. This number is then divided by the total number of students at the school to obtain the racial-ethnic minorities percentage.

More about our data sources and methodologies.

Popular Reports

College Rankings
Best by Location
Degree Guides by Major
Graduate Programs

Compare Your School Options